oxymatrine has been researched along with acitretin in 2 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (acitretin) | Trials (acitretin) | Recent Studies (post-2010) (acitretin) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 1,328 | 95 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, KP; Chen, WG; Ma, W; Shi, HJ; Song, HB; Xia, L; Yang, J; Zhou, H | 1 |
| Bo, KP; Gao, Q; Ma, AL; Ma, W; Shi, HJ; Song, HB; Wang, L; Zhang, N; Zhou, H | 1 |
2 trial(s) available for oxymatrine and acitretin
| Article | Year |
|---|---|
Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
Topics: Acitretin; Adult; Alkaloids; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Keratolytic Agents; Male; Psoriasis; Quality of Life; Quinolizines; Secondary Prevention; Single-Blind Method; Treatment Outcome | 2017 |
Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
Topics: Acitretin; Adult; Alkaloids; Apoptosis; Biopsy; Cell Proliferation; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Keratinocytes; Male; Psoriasis; Quinolizines; Severity of Illness Index; Skin; Treatment Outcome; Young Adult | 2019 |